Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Small Cap Growth Fund” second-quarter ...

Greenhaven Road Capital, an investment management company, released its second-quarter 2025 investor letter. A copy of the ...

On August 18, 2025, Cellebrite DI Ltd. (NASDAQ:CLBT) stock closed at $16.16 per share, with a market capitalization of $3.951 billion.

Cellebrite (CLBT) boasts strong growth potential with robust financials, digital forensics leadership, and a durable moat.

In its updated report, Cellebrite DI Ltd. (NASDAQ:CLBT) climbed to a net income of $19.48 million from a $23.8 million net loss in the same period last year.

Review quarterly and annual revenue, net income, and cash flow for Cellebrite DI Ltd (CLBT:XNAS) stock through the last fiscal year.

In recent trading, shares of Cellebrite DI Ltd (Symbol: CLBT) have crossed above the average analyst 12-month target price of $10.00, changing hands for $10.74/share. When a stock reaches the ...

CLBT stock soars to all-time high, reaching $18.74 Company News Published 10/18/2024, 09:46 AM 0 ...

Review the current Cellebrite DI Ltd (CLBT:XNAS) dividend yield and history to decide if CLBT is the best investment for you.

Cellebrite DI Ltd. (CLBT) key stats comparison: compare with other stocks by metrics: valuation, growth, profitability, momentum, EPS revisions, dividends, ratings.